Scarica l'app Stockscreener
3.88
0.26%
-0.01
Pre-mercato:
3.81
-0.07
-1.80%
Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.89%
27.79
|
31.19 | 31.29 | 18.26 | 24.60 |
| Operating Income/Loss |
10.89%
-27.79
|
-31.19 | -31.29 | -18.26 | -24.60 |
| Nonoperating Income/Loss |
15.57%
1.61
|
1.907 | 2.469 | 2.765 | 2.972 |
| Income/Loss From Continuing Operations Before Tax |
10.58%
-26.18
|
-29.28 | -28.82 | -15.50 | -21.63 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
10.58%
-26.18
|
-29.28 | -28.82 | -15.50 | -21.63 |
|
Net Income/Loss
|
10.58%
-26.18
|
-29.28 | -28.82 | -15.50 | -21.63 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.10%
64.03
|
63.96 | 0.8564 | 63.81 | 63.80 |
| Diluted Average Shares |
0.10%
64.03
|
63.96 | 0.8564 | 63.81 | 63.80 |
| Basic Earnings Per Share |
10.87%
-0.41
|
-0.46 | -0.46 | -0.24 | -0.34 |
| Diluted Earnings Per Share |
10.87%
-0.41
|
-0.46 | -0.46 | -0.24 | -0.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):